Elon Musk, the billionaire entrepreneur known for his high-profile ventures such as Tesla and SpaceX, is once again at odds with the U.S. Securities and Exchange Commission (SEC). Following the SEC’s recent announcement regarding sanctions against him, the situation raises significant questions about compliance, accountability, and the ongoing relationship between high-profile business figures and regulatory
Two decades ago, the journal *Science* introduced the world to the term “microplastics,” illuminating the environmental crisis stemming from minuscule plastic fragments and fibers. Twenty years later, it is evident that our understanding of microplastics has evolved profoundly, yet the scope of the issue appears to have expanded with alarming rapidity. An international collective of
In a groundbreaking move, the federal government has initiated a lawsuit against three dominant pharmacy benefit managers (PBMs) – Caremark, Express Scripts, and OptumRx. The Federal Trade Commission (FTC) argues that these entities are engaging in practices that have drastically inflated the cost of insulin for diabetic patients. Together, these companies handle approximately 80% of
The buzz surrounding the newly acquired Hong Kong action film ‘Stuntman’ highlights the ongoing evolution and endurance of the action genre within cinema. Set to be distributed in the UK and Ireland by Trinity CineAsia, ‘Stuntman’ captivates audiences with its narrative surrounding a once-celebrated action choreographer grappling with obscurity in a swiftly shifting industry landscape.